Search research articles
Contact Us
Filters
Showing results (161-170 of 267) with videos related to
Page
of 27
Sort By:
Open Forum Infectious Diseases
|
July 6, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among HIV-Negative Participants Using Tenofovir/Emtricitabine-Based Preexposure Prophylaxis in 2020: A Substudy of the French National Agency for Research on AIDS and Viral Hepatitis PREVENIR and Inserm SAPRIS-Sero Cohorts
Constance Delaugerre, Lambert Assoumou, Sarah Maylin, et al.
AIDS and Behavior
|
April 27, 2026
Factors Associated with Not Seeking Post-exposure Prophylaxis for HIV Among PrEP-Naive Men Who Have Sex with Men: An Analysis from the French ANRS-PREVENIR Study
Juan Camilo Jones, Marie Costa, Luis Sagaon-Teyssier, et al.
Viruses
|
August 28, 2021
Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2
Nathan Peiffer-Smadja, Antoine Bridier-Nahmias, Valentine Marie Ferré, et al.
Journal of Medical Virology
|
May 29, 2023
Impact of corticosteroids use on midterm sequelae in survivors of COVID-19 admitted to hospital: A prospective cohort study
Nathalie Gault, Delphine Bachelet, Cédric Laouénan, et al.
AIDS (London, England)
|
January 16, 2008
Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients
Jean-François Delfraissy, Philippe Flandre, Constance Delaugerre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 29, 2022
Update of Perinatal Human Immunodeficiency Virus Type 1 Transmission in France: Zero Transmission for 5482 Mothers on Continuous Antiretroviral Therapy From Conception and With Undetectable Viral Load at Delivery
Jeanne Sibiude, Jérôme Le Chenadec, Laurent Mandelbrot, et al.
HIV Clinical Trials
|
April 15, 2016
Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study
Isabelle Poizot-Martin, Eric Bellissant, Rodolphe Garraffo, et al.
Antiviral Therapy
|
March 27, 2009
Prognostic factors for virological response in antiretroviral therapy-naive patients in the MONARK Trial randomized to ritonavir-boosted lopinavir alone
Philippe Flandre, Constance Delaugerre, Jade Ghosn, et al.
AIDS (London, England)
|
October 6, 2018
CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era
Hélène Roul, Murielle Mary-Krause, Jade Ghosn, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
May 15, 2025
Combined screening of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in an emergency department: The URDEPTRIO cross-sectional study
Chris Wong, Quentin Le Hingrat, Florian Salipante, et al.
Page
of 27
Search research articles
Search
Showing results (161-170 of 267) with videos related to
Sort By:
Page
of 27
Open Forum Infectious Diseases
|
July 6, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among HIV-Negative Participants Using Tenofovir/Emtricitabine-Based Preexposure Prophylaxis in 2020: A Substudy of the French National Agency for Research on AIDS and Viral Hepatitis PREVENIR and Inserm SAPRIS-Sero Cohorts
Constance Delaugerre, Lambert Assoumou, Sarah Maylin, et al.
AIDS and Behavior
|
April 27, 2026
Factors Associated with Not Seeking Post-exposure Prophylaxis for HIV Among PrEP-Naive Men Who Have Sex with Men: An Analysis from the French ANRS-PREVENIR Study
Juan Camilo Jones, Marie Costa, Luis Sagaon-Teyssier, et al.
Viruses
|
August 28, 2021
Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2
Nathan Peiffer-Smadja, Antoine Bridier-Nahmias, Valentine Marie Ferré, et al.
Journal of Medical Virology
|
May 29, 2023
Impact of corticosteroids use on midterm sequelae in survivors of COVID-19 admitted to hospital: A prospective cohort study
Nathalie Gault, Delphine Bachelet, Cédric Laouénan, et al.
AIDS (London, England)
|
January 16, 2008
Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients
Jean-François Delfraissy, Philippe Flandre, Constance Delaugerre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 29, 2022
Update of Perinatal Human Immunodeficiency Virus Type 1 Transmission in France: Zero Transmission for 5482 Mothers on Continuous Antiretroviral Therapy From Conception and With Undetectable Viral Load at Delivery
Jeanne Sibiude, Jérôme Le Chenadec, Laurent Mandelbrot, et al.
HIV Clinical Trials
|
April 15, 2016
Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study
Isabelle Poizot-Martin, Eric Bellissant, Rodolphe Garraffo, et al.
Antiviral Therapy
|
March 27, 2009
Prognostic factors for virological response in antiretroviral therapy-naive patients in the MONARK Trial randomized to ritonavir-boosted lopinavir alone
Philippe Flandre, Constance Delaugerre, Jade Ghosn, et al.
AIDS (London, England)
|
October 6, 2018
CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era
Hélène Roul, Murielle Mary-Krause, Jade Ghosn, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
May 15, 2025
Combined screening of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in an emergency department: The URDEPTRIO cross-sectional study
Chris Wong, Quentin Le Hingrat, Florian Salipante, et al.
Page
of 27